Elismetrep

CAS No. 1400699-64-0

Elismetrep( —— )

Catalog No. M34236 CAS No. 1400699-64-0

Elismetrep (MT-8554) is an orally available TRPM8 inhibitor with potential analgesic activity for the study of vasomotor symptoms in postmenopausal women.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 192 Get Quote
5MG 297 Get Quote
10MG 466 Get Quote
25MG 899 Get Quote
50MG 1343 Get Quote
100MG 1773 Get Quote
200MG 2394 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Elismetrep
  • Note
    Research use only, not for human use.
  • Brief Description
    Elismetrep (MT-8554) is an orally available TRPM8 inhibitor with potential analgesic activity for the study of vasomotor symptoms in postmenopausal women.
  • Description
    Elismetrep (MT-8554) is an orally available TRPM8 inhibitor with potential analgesic activity for the study of vasomotor symptoms in postmenopausal women.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Membrane Transporter/Ion Channel
  • Target
    TRP/TRPV Channel
  • Recptor
    TRP/TRPV Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1400699-64-0
  • Formula Weight
    542.53
  • Molecular Formula
    C27H21F3N2O5S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C(O)C1=CC=C(C=C1)S(=O)(=O)N(C=2N=CC3=CC=CC=C3C2C4CC4)CC5=CC=C(OC(F)(F)F)C=C5
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Nonivamide

    A capsaicin analog that acts as an agonist of TRPV1 channel.

  • GFB-8438

    GFB-8438 is a potent and subtype selective inhibitor of TRPC5(IC50s of 0.18 and 0.29 μM of hTRPC5 and hTRPC4, respectively).

  • Linoleoyl Ethanolami...

    Linoleoyl Ethanolamide is an endocannabinoid agent.?It acts by binding to TRPV1 increasing ERK phosphorylation and AP-1 dependent transcription in CB-receptor in an independent manner.